Connell, W.

mucosal healing healing bowel mucosal bowel preservation patient fliximab preservation disease treatment therapy expert panel consensus panel expert crohn remission surgery trial survey hospitalization round flammation factor delphi certolizumab pegol tnf antagonists abbott result response flammatory bowel disease antagonist steering committee topic meeting number certolizumab study gastroenterology disease course table adalimumab bowel function course fliximab treatment outcome question centocor complication pegol score sandborn wj consultant function likelihood timing merck volume flammatory flamm bowel dis rutgeert canada /or ileocolonic ulcers january van assche g clin gastroenterol hepatol feagan delphi survey sandborn post-hoc analysis crp elevation fi ndings treatment goal rutgeerts p endoscopy control steering method increase delphi method